7.80
1.56%
0.12
After Hours:
7.80
Sera Prognostics Inc stock is traded at $7.80, with a volume of 758.20K.
It is up +1.56% in the last 24 hours and up +6.12% over the past month.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
See More
Previous Close:
$7.68
Open:
$7.65
24h Volume:
758.20K
Relative Volume:
4.27
Market Cap:
$257.27M
Revenue:
$306.00K
Net Income/Loss:
$-36.24M
P/E Ratio:
-5.8209
EPS:
-1.34
Net Cash Flow:
$-27.32M
1W Performance:
+8.33%
1M Performance:
+6.12%
6M Performance:
-14.29%
1Y Performance:
+319.35%
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
Nov-19-21 | Initiated | Oppenheimer | Outperform |
Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
Bank of New York Mellon Corp Has $892,000 Holdings in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics, Inc. (NASDAQ:SERA) Shares Sold by Resolute Capital Asset Partners LLC - Defense World
Sera Prognostics President Evguenia Lindgardt Sells 26% Of Holding - Simply Wall St
Ballentine Partners LLC Invests $294,000 in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera prognostics CFO sells over $38k in company stock - Investing.com India
Sera Prognostics CEO sells shares worth $189,893 - Investing.com
Sera prognostics CFO sells over $38k in company stock - Investing.com
Lake Street Advisors Group LLC Makes New $144,000 Investment in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics director sells shares for tax obligations - Investing.com India
Sera Prognostics director sells shares for tax obligations - Investing.com
Sera Prognostics director sells shares for tax obligations By Investing.com - Investing.com Canada
Sera Prognostics director sells shares for tax obligations By Investing.com - Investing.com South Africa
Sera Prognostics (NASDAQ:SERA) Shares Up 0.4% - Defense World
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Quantisnow
(SERA) Proactive Strategies - Stock Traders Daily
Sera Prognostics, Inc. (NASDAQ:SERA) Shares Sold by Vanguard Group Inc. - Defense World
John J. Boniface Sells 5,022 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock - Defense World
Austin Aerts Sells 6,760 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock - Defense World
Zhenya Lindgardt Sells 12,327 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock - Defense World
Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript - Seeking Alpha
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - Kilgore News Herald
Sera Prognostics executive sells $37k in company stock - Investing.com India
Sera prognostics general counsel sells shares worth over $37k - Investing.com
Sera Prognostics CEO sells shares worth over $91k - Investing.com India
Sera Prognostics CIO sells over $37k in company stock - Investing.com
Sera Prognostics CEO sells shares worth over $91k - Investing.com
Sera Prognostics executive sells shares worth over $32,000 - Investing.com
Sera Prognostics CEO sells shares worth over $91k By Investing.com - Investing.com UK
Sera Prognostics executive sells $37k in company stock By Investing.com - Investing.com UK
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - Longview News-Journal
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 - StockTitan
SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS - The Herald Journal
Sera Prognostics (SERA) Set to Announce Quarterly Earnings on Wednesday - Defense World
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 - The Herald Journal
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 - Longview News-Journal
We're Not Worried About Sera Prognostics' (NASDAQ:SERA) Cash Burn - Simply Wall St
Commonwealth Equity Services LLC Trims Stake in Sera Prognostics, Inc. (NASDAQ:SERA) - Defense World
Sera Prognostics trial shows reduced preterm birth complications - Investing.com
Sera Prognostics trial shows reduced preterm birth complications By Investing.com - Investing.com India
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial - Lelezard
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial - Quantisnow
How To Trade (SERA) - Stock Traders Daily
Sera Prognostics added to Russell 2000 and 3000 indexes following conclusion of 2024 indexes annual reconstitution - Utah Business
Selling Buzz: Sera Prognostics Inc [SERA] Chief Executive Officer Lindgardt Zhenya sells 26,867 shares of the company - Knox Daily
Sera Prognostics trial shows reduced preterm birth complications By Investing.com - Investing.com
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10 - Quantisnow
Investor's Toolkit: Key Ratios for Assessing Sera Prognostics Inc (SERA)'s Performance – DWinneX - The Dwinnex
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):